Abstract
Myoclonic twitches (MT) in the submandibular muscles induced by intraventricular administration of D-ala2-met-enkephalinamide (DALA) were studied electromyographically in the rat. Measurement of MT activity was selected since it permits parallel study of the effect of enkephalin on both dopaminergic and serotonergic transmitter systems. The twitches induced by enkephalin were blocked by naloxone, gamma-hydroxybutyrate, and ergometrine, but potentiated by haloperidol. Methysergide did not alter the stimulatory effect of DALA. These results were interpreted as a possibility for a specific enkephalin-induced activation of the so-called inhibition-mediating dopaminergic system, which is sensitive to the blocking action of ergometrine, but resistant to the blocking action of haloperidol.
Similar content being viewed by others
References
Algeri, S., Calderini, G., Consolazione, A., Garratini, S.: The effect of methyonine-enkephalin and D-alanine-methionine-enkephalinamide on the concentration of dopamine metabolites in rat striatum. Eur. J. Pharmacol. 45, 207–209 (1977)
Atweh, S. F., Murrin, L. C., Kuhar, M. J.: Presynaptic localization of opiate receptors in the vagal and accessory optic systems: An autoradiographic study. Neuropharmacology 17, 65–71 (1978)
Bieger, D., Larochelle, L., Hornykiewicz, O.: A model for the quantitative study of central dopaminergic and serotonergic activity. Eur. J. Pharmacol. 18, 128–136 (1972)
Bieger, D.: Influence of striatal dopamine receptor blockade on a bulbar motor reaction. Neuropharmacology 13, 1141–1152 (1974)
Blumberg, J. B., Vetulani, J., Stawarz, R. J., Sulser, F.: The noradrenergic cyclic-AMP generating system in the limbic forebrain: Pharmacological characterization in vitro and possible role of limbic noradrenergic mechanism in the mode of action of antipsychotics. Eur. J. Pharmacol. 37, 357–366 (1976)
Calderini, G., Consolazione, A., Garattini, S., Algeri, S.: Different effects of methionine-enkephalin and (D-ala2) methionine-enkephalin amide on the metabolism of dopamine and norepinephrine in rat brain: Fact or artifact? Brain Res. 146, 392–399 (1978)
Cools, A. R.: Two functionally and pharmacologically distinct dopamine receptors in the rat brain. In: Advances in biochemical psychopharmacology, vol. 16, E. Costa, G. L. Gessa eds., pp. 215–225. New York: Raven 1977
Cools, A. R., v. Dongen, P. A. M., Janssen H.-J., Megens, A. A. H. P.: Functional antagonism between dopamine and noradrenaline within the caudate nucleus of cats: A phenomenon of rhythmically changing susceptibility. Psychopharmacology 59, 231–242 (1978)
Diamond, B. I., Borison, R. L.: Enkephalins and nigrostriatal function. Neurology 28, 1085–1088 (1978)
Dzoljic, M. R., Bonta, I. L., Godschalk, M., Lagendijk, A., Stefanko, S.: EEG-Synchronizing effect of γ-hydroxybutyrate and 1-hydroxy-3-amino-pirrolidone-2 (HA 966) in relation to dopaminergic brain function. Neuropharmacology 14, 591–599 (1975)
Garau, L., Govoni, S., Stefanini, E., Trabucci, M., Spano, P. F.: Dopamine receptors: Pharmacological and anatomical evidences indicate that two distinct dopamine receptor populations are present in rat striatum. Life Sci. 23, 1745–1750 (1978)
Garcia-Sevilla, J. A., Ahtee, L., Magnusson, T., Carlsson, A.: Opiate-receptor mediated changes in monoamine synthesis in rat brain. J. Pharm. Pharmacol. 30, 613–621 (1978)
Godschalk, M., Dzoljic, M. R., Bonta, I. L.: Slow-wave sleep and state resembling absence epilepsy induced in the rat by γ-hydroxybutyrate. Eur. J. Pharmacol. 44, 105–111 (1977)
Iversen, L. L.: Dopamine receptors in the brain. Science 188, 1084–1089 (1975)
Iwamoto, E. T., Way, E. L.: Circling behaviour and stereotypy induced by intranigral opiate microinjections. J. Pharmacol. Exp. Ther. 203, 347–359 (1977)
Jacquet, Y. F., Klee, W. A., Rice, K. C., Iijima, Minamikawa, J.: Stereo-specific and nonstereo-specific effects of (+) and (-) morphine: Evidence for a new class of receptors? Science 198, 842–845 (1977)
Janssen, P. A. J.: The pharmacology of haloperidol. Int. J. Neuropsychiatry 3, 510–518 (1967)
Kebabian, J. W., Petzold, G. L., Greengard, P.: Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the dopamine receptor. Proc. Natl. Acad. Sci. USA 69, 2145–2149 (1972)
König, J. F. R., Klippel, R. A.: The rat brain. A stereotaxic atlas of the forebrain and lower parts of the brain stem. Baltimore: William and Wilkins 1963
Kuschinsky, K.: Actions of narcotics on brain dopamine metabolism and their relevance for psychomotor effect. Arzneim. Forsch. 25, 563–567 (1976)
Lal, H.: Narcotic dependence, narcotic action and dopamine receptors. Life Sci. 17, 483–496 (1975)
Loh, H. H., Brase, D. A., Sampath-Khanna, S., Mar, J. B., Way, E. L.: β-Endorphin in vitro inhibition of striatal dopamine release. Nature 264, 567–568 (1976)
Loon, V. G. R., Kim, C.: Effect of β-endorphin on striatal dopamine metabolism. Res. Commun. Chem. Pathol. Pharmacol. 18, 171–174 (1977)
Menon, M. K., Fleming, R. M., Clark, W. G.: Studies on the biochemical mechanisms of the central effects of gamma-hydroxybutyric acid. Biochem. Pharmacol. 23, 879–885 (1974)
Menon, K., Bieger, D., Hornykiewicz, O.: Pharmacological evidence for a selective antidopaminergic action of gamma-hydroxybutyric acid. J. Neural Transm. 39, 177–186 (1976)
Pert, C. B., Snyder, S. H.: Properties of opiate-receptor binding in rat brain. Proc. Natl. Acad. Sci. USA 70, 2243–2247 (1973)
Stock, G., Magnusson, T., Andén, N.-E.: Increase in brain dopamine after axotomy or treatment with gamma-hydroxybutyric acid due to elimination of nerve impulse flow. Naunyn Schmiedeberg's Arch. Pharmacol. 278, 347–361 (1973)
Walters, J. R., Roth, R. H., Aghajanian, G. K.: Dopaminergic neurons: Similar biochemical and histochemical effects of γ-hydroxybutyrate and acute lesions of the nigrostriatal pathway. J. Pharmacol. Exp. Ther. 186, 630–639 (1973)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dzoljic, M.R., Lely, A.J.v.d. & Mourik, J.B.A.v. Enkephalin-induced myoclonic twitches blocked by ergometrine and potentiated by haloperidol. Psychopharmacology 66, 111–116 (1979). https://doi.org/10.1007/BF00427616
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00427616